KORU Medical Systems Profit Margin 2011-2025 | KRMD
Current and historical gross margin, operating margin and net profit margin for KORU Medical Systems (KRMD) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. KORU Medical Systems net profit margin as of June 30, 2025 is -12.24%.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.181B | $0.034B |
| KORU Medical Systems Inc. is a medical technology company. It focused on development, manufacturing and commercialization of patient-centric large volume subcutaneous infusion solutions. KORU Medical Systems Inc., formerly known as REPRO MEDSYSTEM, is based in MAHWAH, N.J. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.476B | 59.15 |
| Tempus AI (TEM) | United States | $12.470B | 0.00 |
| Doximity (DOCS) | United States | $9.841B | 40.73 |
| Hims & Hers Health (HIMS) | United States | $9.345B | 76.02 |
| IRhythm Technologies (IRTC) | United States | $5.680B | 0.00 |
| Hinge Health (HNGE) | United States | $3.475B | 0.00 |
| Privia Health (PRVA) | United States | $2.879B | 180.08 |
| Heartflow (HTFL) | United States | $2.821B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.501B | 41.38 |
| 10x Genomics (TXG) | United States | $2.126B | 0.00 |
| Enovis (ENOV) | United States | $1.731B | 9.09 |
| Omnicell (OMCL) | United States | $1.652B | 33.77 |
| Azenta (AZTA) | United States | $1.387B | 60.52 |
| Phreesia (PHR) | United States | $1.355B | 0.00 |
| Schrodinger (SDGR) | United States | $1.346B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.333B | 0.00 |
| Claritev (CTEV) | United States | $0.953B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.840B | 0.00 |
| Evolent Health (EVH) | United States | $0.582B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.561B | 0.00 |
| Talkspace (TALK) | United States | $0.560B | 112.67 |
| Veradigm (MDRX) | United States | $0.517B | 0.00 |
| Standard BioTools (LAB) | United States | $0.450B | 0.00 |
| Carlsmed (CARL) | United States | $0.335B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.325B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.294B | 0.00 |
| TruBridge (TBRG) | United States | $0.286B | 13.15 |
| CapsoVision (CV) | United States | $0.231B | 0.00 |
| Outset Medical (OM) | United States | $0.214B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.210B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.201B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.195B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.183B | 0.00 |
| CareCloud (CCLD) | United States | $0.143B | 7.84 |
| EUDA Health Holdings (EUDA) | Singapore | $0.113B | 0.00 |
| Pulmonx (LUNG) | United States | $0.079B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.075B | 0.00 |
| American Well (AMWL) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.058B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.054B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.040B | 0.00 |
| 111 (YI) | China | $0.036B | 0.00 |
| Precipio (PRPO) | United States | $0.033B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.025B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.021B | 0.00 |
| Zhongchao (ZCMD) | China | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Movano (MOVE) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.000B | 0.00 |